Specific immunotherapy (SIT) in atopic dermatitis and food allergy;Spezifische immuntherapie (SIT) bei atopischer dermatitis und nahrungsmittelallergie

Hautarzt

Volumn 59, Issue 7, 2008, Pages 544-550

  Niebuhr, M ^a   Kapp, A ^a   Werfel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Atopic dermatitis; Atopic eczema; Food allergy; Subcutaneous immunotherapy; Sublingual immunotherapy

Indexed keywords

ALLERGEN; CYTOKINE; FOOD ALLERGEN; IMMUNOSUPPRESSIVE AGENT; INSECT VENOM; INTERLEUKIN 4; INTERLEUKIN 5; PLACEBO;

ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; CASE REPORT; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG TOLERABILITY; ECZEMA; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEASONAL VARIATION; SKIN SENSITIZATION;

EID: 46649096800     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-008-1490-6     Document Type: Review

References (60)

1. Maintz L, Novak N (2007) Getting more and more complex: the pathophysiology of atopic eczema. Eur J Dermatol 17: 267-283
2. Boguniewicz M, Leung DY (2006) Atopic dermatitis. J Allergy Clin Immunol 117: 475-480
3. Park JH, Choi YL, Namburg JH et al. (2006) Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol 155: 778-783
4. Breuer K, Wulf A, Constien A et al. (2004) Birch pollen-related food as a provocation factor of allergic symptoms in children with atopic eczema/dermatitis syndrome. Allergy 59: 988-994
5. Reekers R, Busche M, Kapp A, Werfel T (1999) Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 104: 466-472
6. Östblom E, Lilja G, Ahlstedt S et al. (2008) Patterns of antigen-specific IgE-antibodies and reported food hypersensitivity in 4-year-old children. Allergy 63: 418-424
7. Akdis M, Akdis CA (2007) Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119: 780-789
8. Akdis M, Verhagen A, Taylor A (2004) Immune responses in healthy and allergic individuals are characterized by a fine balance between allergenspecific T regulatory and T helper 2 cells. J Exp Med 199: 1567-1575
9. Akdis M, Blaser K, Akdis CA (2005) T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 116: 961-968
10. Augustin M, Zschoke I (2001) Lebensqualität und Ökonomie bei allergischen Hauterkrankungen. Allergologie 24: 433-442
11. Bieber T (1997) Fc epsilon RI-expressing antigen-presenting cells: new players in the atopic game. Immunol Today 18: 311-313
12. Akdis CA, Akdis M, Bieber T et al. (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergy, Asthma and Immunology/PRACTALL Consensus report. J Allergy Clin Immunol 118: 152-169
13. Darsow U, Forer I, Ring J (2005) Spezifische Hyposensibilisierung bei atopischem Ekzem. Allergologie 2: 53-61
14. Di Prisco de Fuenmayor MC, Champion RH (1979) Specific hyposensitization in atopic dermatitis. Br J Dermatol 101: 697-700
15. Galli E, Chini L, Nardi S et al. (1994) Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol Immunopathol 22: 18-22
16. Jonuleit H, Schmitt E, Schuler G et al. (2000) Induction of Interleukin-10-producing, non-proliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192: 1213-1222
17. Jutel M, Akdis M, Budak F et al. (2003) IL-10 and TGF-β cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33: 1205-1214
18. Kapp A (1995) Atopic dermatitis-the skin manifestation of atopy. Clin Exp Allergy 25: 210-219
19. Kleine-Tebbe J, Bergmann KC, Friedrichs F et al. (2006) Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J 15: 56-74
20. Leroy BP, Boden G, Lachapelle JM et al. (1993) A novel therapy for atopic dermatitis: a double-blind, placebo-controlled study. J Am Acad Dermatol 28: 232-239
21. Marshall JS, Leal-Berumen I, Nielsen L et al. (1996) Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J Clin Invest 97: 1122-1128
22. Mastrandrea F, Serio G, Minelli M et al. (2000) Specific sublingual immunotherapy in atopic dermatitis. Results of a 6 year follow-up of 35 consecutive patients. Allergol Immunopathol 28: 54-62
23. Mastrandrea F (2004) The potential role of allergen-specific sublingual immunotherapy in atopic dermatitis. Am J Clin Dermatol 5: 281-294
24. Michils A, Farber CM, Van Hooren JP (1994) Sustained benefit of Interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis. Br J Dermatol 130: 134-135
25. Mosca M, Albani-Rocchetti G, Vignini MA et al. (1993) La vaccinoterapia sub-linguale nella dermatite atopica. G Ital Dermatol Venereol 128: 79-83
26. Novak N, Bieber T, Kraft S (2004) Immunglobulin E-bearing antigen-presenting cells in atopic dermatitis. Curr Allergy Asthma Rep 4: 263-269
27. Nelson HS, Lahr J, Rule R et al. (1997) Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allery Clin Immunol 99: 744-751
28. Pacor ML, Biasi D, Malekina T (1994) The efficacy of long-term specific immunotherapy for Dermatophygoides pteronyssinus in patients with atopic dermatitis. Recenti Prog Med 85: 273-277
29. Pajno GB, Barberio G, De Luca F et al. (2001) Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 31: 1392-1397
30. Pajno GB, Peroni DG, Barberio G et al. (2003) Efficacy of sublingual immunotherapy in asthma and ekzema. Chem Immunol Allergy 82: 77-88
31. Palma-Carlos AG, Spinola-Santos A, Ferreira MB et al. (2001) Immunotherapy in allergic rhinitis. Allerg Immunol 33: 323-326
32. Petrova SI, Berzhets VM, Albanova VI et al. (2001) Immunotherapy in the complex treatment of patients with atopic dermatitis with sensitisation to house dust mites. Zh Mikrobiol Epidemiol Immunobiol 1: 33-36
33. Pichler CE, Helbling A, Pichler WJ (2001) Three years of specific immunotherapy house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of non-specific bronchial hyperreactivity. Allergy 56: 301-306
34. Ring J (1982) Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins. Br J Dermatol 107: 597-602
35. Schandane L, Alonso-Vega C, Willems F et al. (1994) B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 152: 4368-4374
36. Silny W, Czarnecka-Operacz M (2006) Spezifische Immuntherapie bei der Behandlung von Patienten mit atopischer Dermatitis. Ergebnisse einer placebokontrollierten Doppelblindstudie. Allergologie 29: 171-183
37. Staden U, Rolinck-Werninghaus C, Brewe F et al. (2007) Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 62: 1261-1269
38. Szucs T (1996) Sozioökonomische Aspekte der Neurodermitis in Deutschland. In: Riedl-Seifert R (Hrsg) Expert Report zu Bufexamac. W. Zuckschwerdt, München, S 49-65
39. Werfel T, Morita A, Grewe M et al. (1996) Allergen specificity of skin infiltrating T cells is not restricted to a type 2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 107: 871-876
40. Werfel T, Kapp A (1998) Environmental and other major provocation factors in atopic dermatitis. Allergy 53: 731-739
41. Werfel T, Breuer K, Rueff F et al. (2006) Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomised, dose-response study. Allergy 61: 202-205
42. Saarinen KM, Pelkonen AS, Makela MJ, Savilahti E (2005) Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status. J Allergy Clin Immunol 116: 869-875
43. American College of Allergy, Asthma & Immunology. Food allergy: a practice parameter (2006) Ann Allergy Asthma Immunol 96: 1-43
44. Pumphrey RS, Gowland MH (2007) Further fatal allergic reactions to food in the United Kingdom, 1999-2996. J Allergy Clin Immunol 119: 1018-1019
45. Moingeon P, Batard T, Fadel R et al. (2006) Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 59: 151-165
46. Wilson DR, Lima MT, Durham SR (2005) Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60: 4-12
47. Pajno GB (2007) Sublingual immunotherapy: The optimism and the issues. J Allergy Clin Immunol 119: 796-801
48. Pajno GB, Caminiti L, Vita D et al. (2007) Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 120: 164-170
49. Novak N (2007) Allergen specific immunotherapy for atopic dermatitis. J Allergy Clin Immunol 7: 542-546
50. Asero R (1998) Effects of birch pollen specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 28: 1368-1373
51. Bucher X, Pichler WJ, Dahinden CA, Helbling A (2004) Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 59: 1269-1271
52. Möller C (1989) Effect of pollen immunotherapy on food hypersensitivity in children with birch pollinosis. Ann Allergy 62: 342-345
53. Asero R (2003) How long does the effect of birch pollen injection SIT on apple allergy last? Allergy 58: 435-438
54. Hansen KS, Khinchi MS, Skov PS et al. (2004) Food allergy to apple and immunotherapy with birch pollen. Mol Nutr Food Res 48: 441-448
55. Peroni DG, Piacentini GL, Bodini A, Boner AL (2000) Snail anaphylaxis during house dust mite immunotherapy. Pediatr Allergy Immunol 11: 260-261
56. Pajno GB, La Grutta S, Barberio G et al. (2002) Harmful effect of immunotherapy in children with combined snail and mite allergy. J Allergy Clin Immunol 109: 627-629
57. Asero R (2000) Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy. Ann Allergy Asthma Immunol 84: 460-462
58. Kerzl L, Simonowa A, Ring J et al. (2007) Life-threatening anaphylaxix to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J Allergy Clin Immunol 119: 507-508
59. Oppenheimer JJ, Nelson HS, Bock SA et al. (1992) Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 92: 151-152
60. Enrique E, Pineda F, Malek T et al. (2005) Sublingual immunotherapy for hazelnut food allergy: a randomized double blind placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 116: 1073-1079